Thomas Möhler
Impact in
- Hematology top 5%
- Multiple Myeloma Research and Treatments
- Oncology top 10%
- Cutaneous Melanoma Detection and Management
- CAR-T cell therapy research
Papers in
- Hematology 12
- Multiple Myeloma Research and Treatments 12
-
- Immunotherapy and Immune Responses 5
- T-cell and B-cell Immunology 4
- Co-authors
- Carmen Scheibenbogen (7 shared papers)Ulrich Keilholz (7 shared papers)Martina Willhauck (6 shared papers)Peter Brossart (5 shared papers)WERNER HUNSTEIN (4 shared papers)Helmut Näher (1 shared paper)Hjalmar Kurzen (1 shared paper)Stefan Schmitt (1 shared paper)
- Journals
- Blood (8 papers)Journal of Vascular Surgery Venous and Lymphatic Disorders (2 papers)Anti-Cancer Drugs (1 paper)Journal of Investigative Dermatology (1 paper)Cancer Gene Therapy (1 paper)
- Partner nations
- GermanyFranceUnited States
In The Last Decade
Thomas Möhler
25 papers receiving 756 citations
Peers
Comparison fields: 5 of 68
- Hematology 261
- Oncology 298
- Immunology 178
- Genetics 69
- Cell Biology 86
Countries citing papers authored by Thomas Möhler
This map shows the geographic impact of Thomas Möhler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Möhler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Möhler more than expected).
Fields of papers citing papers by Thomas Möhler
This network shows the impact of papers produced by Thomas Möhler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Möhler. The network helps show where Thomas Möhler may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas Möhler, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1993 | 133 | |
| 2 | 2009 | 116 | |
| 3 | 2009 | 89 | |
| 4 | 2003 | 82 | |
| 5 | 2009 | 68 | |
| 6 | 1994 | 54 | |
| 7 | 2011 | 37 | |
| 8 | 2017 | 30 | |
| 9 | 2014 | 25 | |
| 10 | 1997 | 25 | |
| 11 | 2012 | 24 | |
| 12 | 2002 | 20 | |
| 13 | T-cell receptor beta variable region diversity in melanoma metastases after interleukin 2-based immunotherapy. | 1996 | 16 |
| 14 | Restricted T-cell receptor repertoire in melanoma metastases regressing after cytokine therapy. | 2003 | 15 |
| 15 | 2008 | 11 | |
| 16 | 1995 | 10 | |
| 17 | 1999 | 9 | |
| 18 | 1995 | 4 | |
| 19 | 2010 | 3 | |
| 20 | 2003 | 2 |
About Thomas Möhler
Thomas Möhler is a scholar working on Hematology, Immunology, Oncology, Immunology and Allergy and Cell Biology, having authored 26 papers that have together received 778 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (12 papers), Protein Degradation and Inhibitors (5 papers), Immunotherapy and Immune Responses (5 papers), CAR-T cell therapy research (4 papers), T-cell and B-cell Immunology (4 papers), Ubiquitin and proteasome pathways (4 papers), Protease and Inhibitor Mechanisms (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). The work is most often cited by research in Hematology (261 citations), Oncology (298 citations), Immunology (178 citations), Genetics (69 citations) and Cell Biology (86 citations). Thomas Möhler has collaborated with scholars based in Germany, France and United States. Frequent co-authors include Carmen Scheibenbogen, Ulrich Keilholz, Martina Willhauck, Peter Brossart, WERNER HUNSTEIN, Helmut Näher, Hjalmar Kurzen, Stefan Schmitt, Thierry Rème and Tobias Meißner. Their work appears in journals such as Blood, Journal of Vascular Surgery Venous and Lymphatic Disorders, Anti-Cancer Drugs, Journal of Investigative Dermatology and Cancer Gene Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.